SCHEMBL5929000

SCHEMBL5929000

CCCCn1c(-c2c(CC)cccc2CC)nc(-c2ccncc2)c1CN1CCCCC1C1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ HPGD P15428 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929210 0.91 KDM4E (0.35) CYP3A4CYP2D6KCNH2ALDH1A1HPGD
SCHEMBL5929137 0.86 ADORA2B (0.38) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL5928992 0.84 CYP3A4 (0.36) CYP3A4CYP2D6KCNH2ALDH1A1HPGD
SCHEMBL5929060 0.84 CYP3A4 (0.36) CYP3A4CYP2D6KCNH2ALDH1A1HPGD
SCHEMBL5929127 0.82 ALDH1A1 (0.35) CYP3A4CYP2D6ALDH1A1HPGDKDM4E
SCHEMBL5929181 0.82 KMT2A (0.34) CYP3A4ALDH1A1HPGDKDM4ETSHR
SCHEMBL5929118 0.81 KMT2A (0.36) CYP3A4ALDH1A1KDM4ENPSR1POLB
SCHEMBL5929002 0.78 CD274 (0.36) CYP3A4KCNH2ALDH1A1HPGDKDM4E
SCHEMBL5929022 0.78 CYP3A4 (0.38) CYP3A4CYP2D6KCNH2ALDH1A1HPGD
SCHEMBL5928969 0.77 HCRTR1 (0.37) ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 CYP3A4 983/4885CYP2D6 1634/4885KCNH2 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback